We’re taking a brief break this week and, whereas we’re away, we invite you to take pleasure in certainly one of our favourite episodes. We are going to return with a brand-new episode subsequent week!
Immunai is mapping the immune system at unprecedented scale and granularity. The map, paired with machine studying, appears to be like at how the immune system will reply to drug targets, providing an inexpensive approach to stop costly drug failures.
The last word objective is to market immune therapies for illnesses like most cancers quicker than ever earlier than.
On this week’s dialog, Noam Solomon, CEO and co-founder of Immunai, covers the information hole in drug discovery and the way machine studying (ML) can remedy it, how you can de-risk early-stage drug discovery, predictions for AI, and extra.
00:49-01:13: About Immunai
01:13-01:45: Why map the immune system?
01:45-02:44: Are you taking a step again to check the issue to be able to transfer ahead?
02:44-03:49: How tough is it to map the immune system?
03:49-05:29: What’s your AMICA platform?
05:29-07:24: The place does your knowledge come from?
07:24-09:09: How do you account for variations between sufferers?
09:09-11:35: What are the most important challenges to drug growth?
11:35-14:07: How can AI enhance drug growth?
14:07-14:55: Will AI advances pace up drug growth?
14:55-16:06: Is the usage of AI relevant in all illnesses and situations?
16:06-17:48: What units your strategy other than different firms utilizing AI?
17:48-18:54: What partnerships does Immunai have?
18:54-20:24: What are pharma firms in search of from Immunai?
20:24-23:17: How can AI assist with scientific trials?
23:17-24:32: Can AI assist with preventative care?
24:32-26:30: Google Maps for the immune system
26:30-27:18: What’s going to we see from AI in drug discovery within the quick time period?
27:18-28:06: What are the following steps for Immunai?
Excited by being a sponsor of an episode of our podcast? Uncover how one can become involved right here!
Keep up to date by subscribing to our e-newsletter
Why map the immune system?
Are you taking a step again to check the issue to be able to transfer ahead?
How tough is it to map the immune system?
What’s your AMICA platform?
The place does your knowledge come from?
How do you account for variations between sufferers?
What are the most important challenges to drug growth?
How can AI enhance drug growth?
Will AI advances pace up drug growth?
Is the usage of AI relevant in all illnesses and situations?
What units your strategy other than different firms utilizing AI?
What partnerships does Immunai have?
What are pharma firms in search of from Immunai?
How can AI assist with scientific trials?
Can AI assist with preventative care?
Google Maps for the immune system
What’s going to we see from AI in drug discovery within the quick time period?
What are the following steps for Immunai?
